Overview

Evaluation of the Efficacy and Safety of Nifekalant Hydrochloride (NIF) Injection.

Status:
Unknown status
Trial end date:
2020-01-30
Target enrollment:
Participant gender:
Summary
Efficacy and safety evaluation of amiodarone and Nifekalant hydrochloride(NIF) for the treatment of ventricular tachycardia and ventricular fibrillation.
Phase:
Phase 4
Details
Lead Sponsor:
Sichuan Baili Pharmaceutical Co., Ltd.
Treatments:
Amiodarone
Nifekalant